The little mutation suppresses DEN-induced hepatocarcinogenesis in mice and abrogates genetic and hormonal modulation of susceptibility

Carcinogenesis

Volumn 22, Issue 11, 2001, Pages 1853-1862

  Bugni, James M ^a,b   Poole, Therese M ^a,c   Drinkwater, Norman R ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; DIETHYLNITROSAMINE; GROWTH HORMONE; SEX HORMONE;

ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETICS; GONADECTOMY; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; LIVER; LIVER CARCINOGENESIS; LIVER TUMOR; MALE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; PERINATAL CARE; PRIORITY JOURNAL; REGULATORY MECHANISM; SEX DIFFERENCE; TUMOR PROMOTION; TUMOR VOLUME;

EID: 0035159977     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.11.1853     Document Type: Article

References (85)

1. Studies on the occurrence of spontaneous hepatomas in mice of strains C3H and CBA
2. Biological background for experimental work on tumors
3. Strain dependent effects of sex hormones on hepatocarcinogenesis in mice
4. Genetic variation in liver tumor susceptibility, plasma testosterone levels and androgen receptor binding in six inbred strains of mice
5. Effect of neonatal castration on liver tumor induction by N-2-fluorenylacetamide in suckling BALB/c mice
6. Liver and lung tumors in mice exposed at birth to 4-dimethylaminoazobenzene or its 2-methyl or 3′-methyl derivatives
7. Development of broad spectrum of tumors by ethylnitrosourea in mice and the modifying role of age, sex and strain
8. The prenatal exposure of mice to urethan and the consequent development of tumors in various tissues
9. The sex-dependent difference in the development of liver tumors in mice administered dimethylnitrosamine
10. Perinatal mouse liver carcinogenesis as a sensitive carcinogenesis model and the role of the sex hormonal environment in tumor development
11. Roles of ovaries and testes in hepatocellular tumorigenesis induced in mice by 3′-methyl-4-dimethylaminoazobenzene
12. The effect of gonadectomy on the development of hepatomas induced by urethan
13. Certain aspects of hepatocarcinogenesis in the infant mouse model
14. Relevance of basophilic foci to promoting effect of sex hormones on hepatocarcinogenesis
15. Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous
16. Ovariectomy accelerates the growth of microscopic hepatocellular neoplasms in the mouse: Possible association with whole body growth and fat deposition
17. A frame-shift mutation in the androgen receptor gene causes complete androgen insensitivity in the testicular-feminized mouse
18. Comparative study of diethylnitrosamine-initiated two-stage hepatocarcinogenesis in C3H, C57BL and BALB mice promoted by various hepatopromoters
19. Suppression by oestrogen of hepatocellular tumourigenesis induced in mice by 3′-methyl-4-dimethylaminoazobenzene
20. Sex differences in the ultradian pattern of plasma growth hormone concentrations in mice
21. Association between plasma level of growth hormone and sex differentiation of hepatic steroid metabolism in the rat
22. Gene family of male-specific testosterone 16 α-hydroxylase (C-P-450 (16) α) in mouse liver: cDNA sequences, neonatal imprinting and reversible regulation by androgen
23. Pretranslational regulation of sex-dependent testosterone hydroxylases by growth hormone in mouse liver
24. Secretory rhythm of growth hormone regulates sexual differentiation of mouse liver
25. Adrenal histological change and liver-tumor inhibition in hypophysectomized rats fed the azo dye, 3-methyl-4-dimethylaminoazobenzene
26. The inhibition of liver carcinogenesis with 3′-methyl-4-dimethylaminoazobenzene in hypophysectomized rats
27. Further observations on the role of the pituitary and the adrenal gland in azo dye carcinogenesis
28. The role of hormones in liver carcinogenesis
29. Inhibitory effect of hypothalamic lesions on liver tumor induction by N-2-fluorenylacetamide in male rats
30. Role of the pituitary in N-2-fluorenyldiacetamide carcinogenesis
31. Effects of neonatal and adult castration and of testosterone substitution in male rats on growth of enzyme-altered hepatic foci in the resistant hepatocyte model
32. Growth hormone modifies the growth rate of enzyme-altered hepatic foci in male rats treated according to the resistant hepatocyte model
33. Pituitary grafts modify sex differences in liver tumor formation in the rat following initiation with diethylnitrosamine and different promotion regimens
34. On mechanisms of sex differences in chemical carcinogenesis: Effects of implantation of ectopic pituitary grafts on the early stages of liver carcinogenesis in the rat
35. New murine model for hepatocellular carcinoma: Transgenic mice expressing metallothionein-ovine growth hormone fusion gene
36. The expression of a metallothionein-ovine growth hormone fusion gene in transgenic mice does not impair fertility but results in pathological lesions in the liver
37. Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice
38. Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6
39. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function
40. Molecular basis of the little mouse phenotype and implications for cell type-specific growth
41. Etiology of growth hormone deficiency in little, Ames and Snell dwarf mice
42. Analysis of growth hormone genes in mice with genetic defects of growth hormone expression
43. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4
44. Prolactin status of hereditary dwarf mice
45. 'Short' loop feedback regulation of hypothalamic and brain thyrotropin-releasing hormone content in the rat and dwarf mouse
46. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice
47. Chromosome mapping of murine susceptibility loci to liver carcinogenesis
48. Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones
49. A gene that determines the high susceptibility of the C3H/HeJ strain of mouse to liver tumor induction is located on Chromosome 1
50. Identification of hepatocarcinogen-resistance genes in DBA/2 mice
51. Biometry
52. Induction of three histochemically distinct populations of hepatic foci in C57BL/6J mice
53. Correlation between Bcl-2 expression and histopathology in diethylnitrosamine-induced mouse hepatocellular tumors
54. Rapid growth of preneoplastic lesions in hepatocarcinogen-sensitive C3H/HeJ male mice relative to C57BL/6J mice
55. Rapid typing of the little mouse mutation
56. Age- and sex-associated diethylnitrosamine dealkylation activity of the mouse liver and hepatocarcinogenesis
57. A colorimetric determination of acetaldehyde in blood
58. High variability of nitrosamine metabolism among individuals: Role of cytochromes P450 2A6 and 2E1 in the dealkylation of N-nitrosodimethylamine and N-nitrosodiethylamine in mice and humans
59. Receptor-associated resistance to growth hormone-releasing factor in dwarf 'little' mice
60. Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1'-hydroxyestragole in the mouse and mutagenicity of 1'-acetoxyestragole in bacteria
61. Genetic analysis of multistage hepatocarcinogenesis
62. Prolactin and growth hormone levels in different inbred strains of mice: Patterns in association with estrous cycle, time of day and perphenazine stimulation
63. Strain specific sensitivity to diethylnitrosamine-induced carcinogenesis is maintained in hepatocytes of C3H/HeN in equilibrium with C57BL/6N chimeric mice
64. Genetic diseases and developmental defects analyzed in allophenic mice
65. Influence of gonadal steroids on age- and sex-related secretory patterns of growth hormone in the rat
66. Pathological endpoints in dietary restricted rodents-Fischer 344 rats and B6C3F1 mice
67. Caloric restriction profoundly inhibits liver tumor formation after initiation by 6-nitrochrysene in male mice
68. Roles for insulin-like growth factor-1 in mediating the anti-carcinogenic effects of caloric restriction
69. Metabolic control of sexual function and growth: Role of neuropeptide Y and Leptin
70. Moderate caloric restriction alters the subcellular distribution of somatostatin mRNA and increases growth hormone pulse amplitude in aged animals
71. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)
72. Growth hormone activation of Stat 1, Stat 3 and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation
73. In vivo growth hormone treatment rapidly stimulates the tyrosine phosphorylation and activation of Stat3
74. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
75. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
76. Effects of growth hormone on the expression of c-myc and c-fos during early stages of sex-differentiated rat liver carcinogenesis in the resistant hepatocyte model
77. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone
78. Plasma growth hormone pattern regulates epidermal growth factor (EGF) receptor messenger ribonucleic acid levels and EGF binding in the rat liver
79. Growth hormone regulates the rodent hepatic epidermal growth factor receptor at a pretranslational level
80. Development of liver tumors in transforming growth factor α transgenic mice
81. Role of insulin-like growth factors in embryonic and postnatal growth